Problem statement: Answer the MCQ question.
Question: Which drug exhibits a 13.727\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a. CC(C)C(=O)Nc1c2c(nn1-c1ccc(F)cc1)CS(=O)(=O)C2
b. COc1cc(NC(=O)C2CCN(S(=O)(=O)c3ccc4[nH]c(=O)oc4c3)CC2)cc(OC)c1
c. Cn1ncc2c(NCc3cccc(C(F)(F)F)c3)c(C(=O)O)cnc21
Answer: a. CC(C)C(=O)Nc1c2c(nn1-c1ccc(F)cc1)CS(=O)(=O)C2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)C(=O)Nc1c2c(nn1-c1ccc(F)cc1)CS(=O)(=O)C2
CC(C)C(=O)Nc1c2c(nn1-c1ccc(F)cc1)CS(=O)(=O)C2
N-[2-(4-fluorophenyl)-5,5-dioxo-4,6-dihydrothieno[3,4-c]pyrazol-3-yl]-2-methylpropanamide